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Background
IgE mediated cow’s milk allergy (CMA) is a frequent
disease in pediatric population, and challenge tests are
considered gold standard in its diagnosis, although its
use is limited in clinical practice. An appropriated ana-
mnesis and laboratorial analysis are the most frequent
and feasible used tools. The aim of this study was to
evaluate the role of these practices in IgE mediated
CMA diagnosis.
Methods
It was a retrospective study based on patient data charts
from a reference center in food allergy. All patients who
performed open, single or double blind placebo con-
trolled oral food challenges (OFC) for CMA diagnosis
were included. Clinical history was defined as suggestive
when patients presented at any time anaphylaxis, urti-
caria, angioedema, laryngeal edema and dyspnea. Diar-
rhea, vomiting, cough, wheezing, rhinoconjunctivitis,
pruritus and erythema were considered as dubious.
Symptoms onset <2 hours after food ingestion was also
considered suggestive. Dubious and/or subjective symp-
toms or delayed ones were considered undetermined.
Specific IgE (sIgE) was included when evaluated ± 12
months from OFC. Skin prick test was considered posi-
tive when wheal was >3mm and/or serum specific IgE
>0.35 kU/L. Sensitivity (Se), specificity (Sp), positive and
negative predictive value (PPV and NPV) and likelihood
ratio (LR) were established, comparing anamnesis, ana-
phylaxis, laboratorial tests versus OFC.
Results
92 patients were included (43 OFC+; 49 OFC-). The med-
ian age at challenge test was 2.5 years (0.4-10.7) (OFC+
3.0y; OFC- 2.4y). The median time between symptoms
onset and food challenge was 2.3 years (0.2-10.4) (OFC+
2.7; OFC- 2.2). Suggestive clinical history was present in
93% of patients in OFC+, compared to 61% of patients in
OFC- (Se 93%; Sp 38%; PPV 57%; NPV 86%; LR 1.51;
p<0.05). Considering only anaphylactic symptoms versus
OFC the results were Se 44%; Sp 87%; PPV 76%; NPV 64%
and LR 3.06 (p<0.05). Specific IgE was present in 100% of
patients in OFC+ resulting in Se 100%; Sp 48%; PPV 63%;
NPV 100% and LR 1.96 (p<0.05). Suggestive clinical his-
tory associated with symptoms onset <2 hours and pre-
sence of sIgE demonstrated a Se 88%; Sp 73%; PPV 74%;
NPV 88% and LR 3.3 (p<0.05).
Conclusions
Suggestive clinical history associated to positive sIgE was
helpful on the diagnosis of CMA. Generally, the OFC
remains necessary to set or exclude diagnosis. Negative
sIgE was useful to exclude CMA.
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